Genomics and Cancer Epigenetics

Genomics and Cancer Epigenetics focus on understanding the genetic and epigenetic changes that drive cancer development and progression. Genomics refers to the study of an organism's complete set of DNA, including all its genes. In cancer, genomic research seeks to identify mutations, genetic alterations, and abnormal gene expressions that contribute to tumor growth, helping to develop targeted therapies. Cancer epigenetics examines changes in gene expression that are not caused by alterations in the DNA sequence itself, but by other mechanisms such as DNA methylation, histone modification, or non-coding RNA activity. These epigenetic changes can activate oncogenes or silence tumor suppressor genes, contributing to cancer. Understanding both genomic and epigenetic factors is crucial for developing personalized cancer treatments and predicting patient outcomes.

    Related Conference of Genomics and Cancer Epigenetics

    April 28-29, 2025

    35th Experts Meet On Cancer Research & Therapy

    Paris, France
    May 26-27, 2025

    15th World Congress on Breast Cancer

    Rome, Italy
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    July 28-29, 2025

    45th Euro Congress on Cancer Science & Therapy

    Paris, France
    August 18-19, 2025

    6th Cancer Diagnostics & Treatment Conference

    Rome, Italy
    October 13-14, 2025

    8th International Conference on Anti-Cancer Drugs & Therapies

    Aix-en-Provence, France
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain
    November 24-25, 2025

    43rd World Cancer Conference

    Barcelona, Spain

    Genomics and Cancer Epigenetics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in